Reduced intensity stem cell transplant can cure blood cancers in older patients

12/8/2013 |

A new study shows that nonmyeloablative, related haploidentical blood stem cell transplants can help eliminate the disease in older patients up to 75 years of age. Researchers found similar benefits among participants in their 50s, 60s and 70s, suggesting that age is not a barrier to successful outcomes after half-matched transplant. "These results underscore that a reduced-intensity, related haploidentical transplant should be considered a very reasonable treatment option for suitable patients up to at least age 75 who require a transplant," said lead researcher Dr. Yvette Kasamon of the Johns Hopkins Kimmel Cancer Center.

View Full Article in:

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Executive Officer
UCare Minnesota
Minneapolis, MN